News & Insight
31 March 2021
Blog
The microbiome: a biomarker for colorectal cancer?
Findings from the OPTIMISTICC team point towards a global microbiome signature for colorectal cancer that could help improve the way we detect the disease.
Colorectal cancer is the third most common cancer in the world. With more than 1.8…
Latest publication
Latest tweet
#Cachexia is one of the biggest problems we deal with in solid tumour oncology. Check out our piece from… https://t.co/83G2L7seSS Mon Apr 12 11:45:00 +0000 2021
News and insight archive
Blog
Findings from the OPTIMISTICC team point towards a global microbiome signature for colorectal cancer that could help improve the way we detect the disease.
Colorectal cancer is the third most common cancer in the world…
31 March 2021
Blog
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our blog series, members of our Cancer Grand Challenges Scientific Committee…
30 March 2021
Video
We recently held a webinar with the American Association for Cancer Research (AACR) providing an overview of the Cancer Grand Challenges partnership between Cancer Research UK and the US National Cancer Institute. …
30 March 2021
News
New findings from the Cancer Grand Challenges PRECISION team suggest adipocyte size and COX2 expression could help to identify which people with ductal carcinoma in situ (DCIS) are at high-risk of developing invasive…
22 March 2021
Blog
Patient advocate Candace Henley and physician-scientist Kimmie Ng are members of the Cancer Grand Challenges OPTIMISTICC team. Together they have helped to set up the programme's flagship study, MICROCOSM.
An…
11 March 2021
News
Amy Schade joined Karen Cichowski’s lab (Brigham and Women's Hospital, Harvard Medical School) as a postdoctoral research fellow in 2019. Karen is Amy’s mentor, and both are part of the Cancer Grand Challenges…
10 March 2021
Blog
Flaminia Grimaldi, Sara Vogl and Laura Kütt are members of the IMAXT team, working on Theia, an immersive interface to interact with 3D tumours in VR. Their broad range of expertise – a VR artist, a designer and an…
9 March 2021
Blog
Michele Cleary is CEO of The Mark Foundation for Cancer Research, co-funders of the Cancer Grand Challenges SPECIFICANCER team. For International Women’s Day 2021 and our Cancer Grand Challenges Women's Week series, we…
8 March 2021
Blog
Barbara Rimer is our newest member of the Cancer Grand Challenges Scientific Committee. For International Women’s Day 2021 and as part of our Cancer Grand Challenges Women's Week series, we caught up to discuss the…
8 March 2021